Document is current
Any future updates will be listed below
-
Authors
XiangWei, Wenshu https://orcid.org/0000-0003-2456-4057
Perszyk, Riley E.
Liu, Nana
Xu, Yuchen
Bhattacharya, Subhrajit
Shaulsky, Gil H.
Smith-Hicks, Constance
Fatemi, Ali
Fry, Andrew E.
Chandler, Kate
Wang, Tao
Vogt, Julie
Cohen, Julie S.
Paciorkowski, Alex R.
Poduri, Annapurna
Zhang, Yuehua
Wang, Shuang
Wang, Yuping
Zhai, Qiongxiang
Fang, Fang
Leng, Jie
Garber, Kathryn
Myers, Scott J.
Jauss, Robin-Tobias
Park, Kristen L. https://orcid.org/0000-0001-5527-3047
Benke, Timothy A. https://orcid.org/0000-0002-6969-5061
Lemke, Johannes R. https://orcid.org/0000-0002-4435-6610
Yuan, Hongjie https://orcid.org/0000-0002-8127-7145
Jiang, Yuwu https://orcid.org/0000-0002-5179-9807
Traynelis, Stephen F. https://orcid.org/0000-0002-3750-9615
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS111619)
National Institute of Mental Health (MH127404)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD103538)
- License Information
-
More Information
Article History
Received: 10 May 2023
Revised: 27 September 2023
Accepted: 28 September 2023
First Online: 3 November 2023
Declarations
:
: SFT is a member of the SAB for Sage Therapeutics, Eumentis Therapeutics, the GRIN2B Foundation, the CureGRIN Foundation, and CombinedBrain. SFT is consultant for GRIN Therapeutics and Neurocrine, a cofounder of NeurOp, Inc. and Agrithera, and a member of the Board of Directors for NeurOp Inc. HY is the PI on a research grant from Sage Therapeutics to Emory and SJM is PI on a grant from GRIN Therapeutics to Emory. TAB – Consultancy for AveXis, Ovid, GW Pharmaceuticals, International Rett Syndrome Foundation, Takeda, Taysha, CureGRIN, GRIN Therapeutics, Alcyone, Neurogene, and Marinus; Clinical Trials with Acadia, Ovid, GW Pharmaceuticals, Marinus and RSRT; all remuneration has been made to his department.
: This study was approved by the Medical Ethics Committee and the Institutional Review Boards of University of Colorado School of Medicine and Children's Hospital Colorado (COMIRB 16–1520), Peking University First Hospital, John Hopkins University, Birmingham Women’s and Children’s Hospital, Emory University, and University of Leipzig Hospitals and Clinics. All in vitro studies were conducted according to the guidelines of Emory University.
